Trade BioNTech BNTX

Sell
 Buy

BioNTech live chart

5m 15m 30m 1h 4h 1d 1w

instrument_fundamentals

Weekly Search
Weekly
Daily
date Close change Change (%) instr__open High Low

instr__news

Webhose 2025 Apr 26, 12:58

Gilder Gagnon Howe & Co. LLC Raises Stock Position in BioNTech SE (NASDAQ:BNTX)

BioNTech SE
Webhose 2025 Apr 26, 10:48

Top Biotech Stocks To Watch Now - April 25th

BioNTech SE
Webhose 2025 Apr 25, 21:41

SMMT Stock Declines Amid Akeso's FDA Approval News

BioNTech SE
Webhose 2025 Apr 25, 20:30

Merck's (MRK) Keytruda Gains as Akeso and Summit Struggle with Survival Data | BNTX Stock News

BioNTech SE
Webhose 2025 Apr 25, 18:48

Summit Therapeutics (SMMT) Gains Attention Amid New Drug Approval in China | BNTX Stock News

BioNTech SE
Webhose 2025 Apr 25, 18:25

BioNTech (BNTX) Showcases Oncology Advances at AACR 2025

BioNTech SE
Webhose 2025 Apr 25, 18:15

Akeso (AKESF) and Summit Therapeutics (SMMT) See Stock Declines After Drug Data Release | BNTX ...

BioNTech SE
Webhose 2025 Apr 25, 10:23

BioNTech SE (NASDAQ:BNTX) Stock Holdings Lessened by Altrinsic Global Advisors LLC

BioNTech SE
Webhose 2025 Apr 25, 10:20

First Trust Advisors LP Trims Stake in BioNTech SE (NASDAQ:BNTX)

BioNTech SE
Webhose 2025 Apr 24, 11:55

BioNTech to Present Clinical and Preclinical Data Across mRNA and Next-Generation ...

BioNTech SE
Webhose 2025 Apr 24, 11:55

BioNTech SE (BNTX) Showcases Oncology Pipeline Progress at AACR 2025 | BNTX stock news

BioNTech SE
Webhose 2025 Apr 24, 11:16

8,767 Shares in BioNTech SE (NASDAQ:BNTX) Acquired by Diadema Partners LP

BioNTech SE
Webhose 2025 Apr 24, 11:10

BioNTech to Present Clinical and Preclinical Data Across mRNA and Next-Generation Immuno-Oncology Priority Programs at AACR 2025 | The Manila Times

BioNTech SE
Webhose 2025 Apr 23, 17:19

BioNTech (BNTX) to Announce Q1 2025 Financial Results

BioNTech SE
Webhose 2025 Apr 23, 17:19

BioNTech (BNTX) Advances Cancer Treatment Trials and IP Defense

BioNTech SE
Webhose 2025 Apr 23, 10:48

Q1 Earnings Forecast for BioNTech Issued By Leerink Partnrs

BioNTech SE
Webhose 2025 Apr 23, 08:42

Marshall Wace LLP Increases Holdings in BioNTech SE (NASDAQ:BNTX)

BioNTech SE
Webhose 2025 Apr 22, 12:01

BioNTech SE to Announce Q1 2025 Financial Results | BNTX stock news

BioNTech SE
Webhose 2025 Apr 22, 11:05

BioNTech to Report First Quarter 2025 Financial Results and Corporate Update on May 5, 2025 | The Manila Times

BioNTech SE
Webhose 2025 Apr 21, 20:37

BioNTech SE (BNTX) Q4 2024 Earnings Call Highlights: Navigating Challenges and Advancing Innovations

BioNTech SE
Webhose 2025 Apr 21, 09:00

Bridgewater Associates LP Increases Holdings in BioNTech SE (NASDAQ:BNTX)

BioNTech SE
Webhose 2025 Apr 19, 11:40

BioNTech SE (NASDAQ:BNTX) Shares Sold by Capital International Inc. CA

BioNTech SE
Webhose 2025 Apr 18, 10:01

Finward Bancorp Makes New Investment in BioNTech SE (NASDAQ:BNTX)

BioNTech SE
Webhose 2025 Apr 18, 07:26

What the Newest mRNA Vaccines Could Do Beyond COVID

BioNTech SE
Webhose 2025 Apr 14, 17:34

BioNTech (NasdaqGS:BNTX) Sees 11% Stock Increase Over Last Week

BioNTech SE
Webhose 2025 Apr 14, 17:32

BioNTech (BNTX) Dominates German Stocks Among Hedge Funds

BioNTech SE
Webhose 2025 Apr 13, 11:52

BioNTech SE (NASDAQ:BNTX) Shares Sold by Quinn Opportunity Partners LLC

BioNTech SE
Webhose 2025 Apr 13, 10:27

Scotia Capital Inc. Acquires 30,143 Shares of BioNTech SE (NASDAQ:BNTX)

BioNTech SE
Webhose 2025 Apr 11, 00:00

Sen. Johnson demands COVID vaccine makers hand over all documents, communications, as evidence against their products reaches a climax - NaturalNews.com

BioNTech SE
Webhose 2025 Apr 09, 08:30

Franklin Resources Inc. Buys 133,402 Shares of BioNTech SE (NASDAQ:BNTX)

BioNTech SE
Webhose 2025 Apr 06, 09:07

Cinctive Capital Management LP Buys Shares of 14,760 BioNTech SE (NASDAQ:BNTX)

BioNTech SE
Webhose 2025 Apr 02, 19:37

Is BioNTech SE (BNTX) the Best German Stock to Buy According to Hedge Funds?

BioNTech SE
Webhose 2025 Apr 02, 12:01

BioNTech (NASDAQ:BNTX) Price Target Cut to $145.00 by Analysts at HC Wainwright

BioNTech SE
Webhose 2025 Apr 02, 11:07

Groupama Asset Managment Buys 19,994 Shares of BioNTech SE (NASDAQ:BNTX)

BioNTech SE
Webhose 2025 Apr 02, 06:30

BioNTech SE (NASDAQ:BNTX) Receives Consensus Rating of "Moderate Buy" from Brokerages

BioNTech SE
Webhose 2025 Apr 01, 17:17

BioNTech (NASDAQ:BNTX) Shares Gap Down - Time to Sell?

BioNTech SE
Webhose 2025 Mar 29, 15:50

Analysts' Top Healthcare Picks: Ascentage Pharma Group International Unsponsored ADR (AAPG), BioNTech SE (BNTX) | Markets Insider

BioNTech SE

BioNTech news

Tommy Yap 2025 Mar 04, 16:00

Week Ahead: U.S. Inflation Data and BoC Policy Rate in Focus

Forex Indices
Moderna Share Price
Georgy Istigechev 2024 Jan 03, 08:01

Moderna share price jumps as Oppenheimer upgrades stock

Shares
Pfizer shares sink as revenue prospects
Georgy Istigechev 2023 Dec 14, 05:13

Pfizer shares sink on lower COVID revenue prospects

Shares
shutterstock_1781525795.jpg
Zachariah Walker 2023 Feb 14, 09:11

5 Stocks to Fall in Love with this Valentines Day

2021 Aug 24, 08:05

Stocks make further gains as oil bounce carries on

Latest news

Show more
Frances Wang 2025 Apr 27, 16:00

ETFs That Outperform the S&P 500: ARKK, VGT, IWF, XBI

ETFs
Frances Wang 2025 Apr 27, 16:00

Forex Market Today: Analyzing Seasonal Patterns in Forex Market Trends

Forex
Frances Wang 2025 Apr 27, 16:00

Dow Jones today: Major Indexes Rise as Trump Signals Softer Trade Stance

Stocks
Tommy Yap 2025 Apr 27, 16:00

Morning Note: Gold Dips on Dollar Strength, ECB Eyes Rate Cut, Japan Denies FX Pressure

Morning Note Commodities Forex
Tommy Yap 2025 Apr 26, 21:00

Week Ahead: Canada Election and U.S. NFP in Focus

Forex Indices
Frances Wang 2025 Apr 24, 16:00

How will tariffs affect forex: EUR/USD pair weakens amid trade uncertainty

Forex
Frances Wang 2025 Apr 24, 16:00

Exchange Traded Funds News: Tech-Focused ETFs Gain Traction Amid AI Boom

ETFs
Tommy Yap 2025 Apr 24, 16:00

Morning Note: US-China Trade Deadlock; Nvidia's AI Leap; Canada Votes

Morning Note CAD Forex

Info

Spread

1.2832

Spread (%)

1.2234 %

Leverage

1:10

Overnight Interest Buy

-0.0597 %

Overnight Interest Sell

-0.0292 %

Currency

USD

Trading Hours

Market open

Monday

13:31 - 19:59

Tuesday

13:31-19:59

Wednesday

13:31-19:59

Thursday

13:31-19:59

Friday

13:31-19:59

instr__analysis_statistics

instr__open

---

instr__close

---

instr__52week_range

--- – ---

instr__market_cap

28976943104

instr__shares_outstand

240392992

instr__earnings_date

0000-00-00

instr__dividend_date

2022-06-17

instr__ex_dividend_date

2022-06-02

instr__forward_annual_dividend_rate

0

instr__forward_annual_dividend_yield

0

instr__eps

-3.14

instrument_learn_more

BioNTech BioNTech SE
BioNTech SE, a biotechnology company, develops and commercializes immunotherapies to treat cancer and infectious diseases in Germany. The company develops BNT111, which is in Phase 2 clinical trial for advance melanoma; BNT113, which is in Phase 2 clinical trial to treat head and neck squamous cell carcinoma; BNT116, which is in Phase I clinical trial for non-small cell lung cancer; BNT142, which is in phase 1/2 clinical trial for multiple solid tumors; BNT151, which is in phase 1/2 clinical trial for solid tumors; BNT152+BNT153, which is in phase 1 clinical trial for solid tumors; and BNT122/RO7198457, which is in Phase 2 clinical trial to treat adjuvant high-risk muscle-invasive urothelial carcinoma, colorectal cancer, pancreatic ductal adenocarcinoma, advance melanoma, as well as in phase 1a/1b clinical trial for advanced/metastatic solid tumors. It also develops BNT211, which is in phase 1 clinical trial to treat CLDN6+ solid tumors; BNT221, phase 1 clinical trial for the treatment of cancer; BNT311/GEN1046 (acasunlimab), which is in phase 3 clinical trial for solid tumors; BNT312/GEN1042, which is in phase 1/2 and 1 clinical trial to treat solid tumors; BNT314/GEN1059, which is in Phase 1/2 clinical trial for advanced or metastatic solid tumors; BNT315/GEN1055, which is in phase 1/2 clinical trial for advanced solid tumors; BNT317, which is in phase 1 clinical trial for advanced solid tumors; BNT327, which is in phase 1/2, 2, and 3 clinical trial to treat small cell lung cancer, advanced/metastatic tnbc, neuroendocrine neoplasm, malignant mesothelioma, EGFR-mutant non-squamous, hepatocellular carcinoma, and advanced solid tumors; and BNT316/ONC-392, which is in phase 1/2, 2, and 3 clinical trial to treat metastatic, non-small cell lung cancer, platinum-resistant ovarian cancer, metastatic castration resistant prostate cancer, and advanced or metastatic solid tumor. BioNTech SE was incorporated in 2008 and is headquartered in Mainz, Germany.
Markets.com Bonus Trading

related_instruments

Asset
Sell
Buy
Change (%)

trade_now_btn

trade_now_btn

trade_now_btn

trade_now_btn
view_all_instruments

latest_education_articles

Show more
Markets.com Bonus Trading
Trustpilot